Editas Medicine
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Editas Medicine generated cash of -$132,178,000, which is more than the previous year. Cash used in financing activities reached the amount of $118,039,000 last year. Net change in cash is therefore -$17,870,000.
Cash Flow
| 2014 | -8.65M | -1.21M | 18.48M |
|---|---|---|---|
| 2015 | -5.40M | -1.43M | 139.39M |
| 2016 | -49.92M | -5.09M | 97.16M |
| 2017 | -9.41M | -183.81M | 154.53M |
| 2018 | -45.70M | -53.08M | 86.94M |
| 2019 | -40.66M | 12.25M | 131.82M |
| 2020 | -179.84M | -140.52M | 224.12M |
| 2021 | -163.80M | -54.46M | 282.10M |
| 2022 | -177.34M | 114.06M | 1.28M |
| 2023 | -132.17M | -3.73M | 118.03M |
0IFK.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 145.39M | 207.39M | 143.55M | 239.80M | 136.39M | 148.24M | 186.94M | 143.18M | 10.62M | 2.01M |
Operating activities | ||||||||||
Net income | -153.21M | -220.43M | -192.50M | -115.97M | -133.74M | -109.95M | -120.32M | -97.18M | -72.9M | -13.68M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 6.06M | 6.33M | 5.05M | 3.95M | 2.83M | 3.25M | 2.68M | 1.20M | 471K | 157K |
Stock-based compensation expense | 19.79M | 29.29M | 43.39M | 23.15M | 27.24M | 0 | 23.36M | 16.88M | 3.51M | 55K |
| Deferred income tax benefit | 19.79M | 29.29M | 43.39M | 23.15M | 27.24M | 0 | 23.36M | 16.88M | 3.51M | 55K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -5.04M | -4.87M | 5.78M | -5.63M | -388K | 649K | -591K | 931K | -1.01M | 0 |
Inventories | 0 | 0 | -3.34M | -5.65M | 10.65M | 1.57M | -8.94M | 13.10M | 4.80M | 0 |
Accounts payable | -1.49M | 4.36M | -1.13M | 855K | 274K | 1.78M | -1.51M | 3.25M | -1.43M | 2.19M |
Cash generated by operating activities | -132.17M | -177.34M | -163.80M | -179.84M | -40.66M | -45.70M | -9.41M | -49.92M | -5.40M | -8.65M |
Investing activities | ||||||||||
Purchases Of Investments | -258.51M | -315.18M | -408.89M | -458.40M | -342.18M | -459.37M | -375.26M | 0 | 241K | 0 |
Investments In Property Plant And Equipment | -4.71M | -4.11M | -7.97M | -7.16M | -6.16M | -4.75M | -2.05M | -3.49M | -1.43M | -1.21M |
Acquisitions Net | 0 | 18K | 46.48M | 12K | 102K | 37K | 15K | 20K | 0 | 0 |
Cash generated by investing activities | -3.73M | 114.06M | -54.46M | -140.52M | 12.25M | -53.08M | -183.81M | -5.09M | -1.43M | -1.21M |
Financing activities | ||||||||||
Common Stock Issued | 117.07M | 979K | 282.10M | 224.12M | 116.34M | 0 | 154.14M | 97.48M | 6K | 41K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11K | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | -857K | -764K | -560K | -500K | -462K |
Cash used in financing activities | 118.03M | 1.28M | 282.10M | 224.12M | 131.82M | 86.94M | 154.53M | 97.16M | 139.39M | 18.48M |
Net Change In Cash | -17.87M | -61.99M | 63.83M | -96.24M | 103.40M | -11.85M | -38.69M | 42.14M | 132.55M | 8.61M |
Cash at end of period | 127.52M | 145.39M | 207.39M | 143.55M | 239.80M | 136.39M | 148.24M | 185.32M | 143.18M | 10.62M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |